Cover Image
Market Research Report

Global G-CSF Biosimilars Market Insights, Forecast to 2025

Published by QYResearch Product code 884727
Published Content info 117 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global G-CSF Biosimilars Market Insights, Forecast to 2025
Published: July 9, 2019 Content info: 117 Pages
Description

Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor

Company profiles are primarily based on public domain information including company:

  • Merck & Co.
  • Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Pfizer
  • Novartis
  • Roche

The global G-CSF Biosimilars market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the G-CSF Biosimilars market based on company, product type, end user and key regions.

This report studies the global market size of G-CSF Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of G-CSF Biosimilars in these regions.

This research report categorizes the global G-CSF Biosimilars market by top players/brands, region, type and end user. This report also studies the global G-CSF Biosimilars market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.
  • Sanofi
  • Johnson & Johnson
  • Gilead Science
  • GlaxoSmithKline
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer

Market size by Product:

  • Human Growth Hormone
  • Erythropoietin
  • Monoclonal Antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor

Market size by End User:

  • Blood Disorders
  • Oncology Diseases
  • Chronic And Autoimmune Diseases
  • Growth Hormone Deficiencies

Market size by Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Egypt
    • South Africa

The study objectives of this report are:

  • To study and analyze the global G-CSF Biosimilars market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of G-CSF Biosimilars market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global G-CSF Biosimilars companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of G-CSF Biosimilars submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of G-CSF Biosimilars are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of G-CSF Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1. Study Coverage

  • 1.1. G-CSF Biosimilars Product
  • 1.2. Market Segments
  • 1.3. Key Manufacturers Covered
  • 1.4. Market by Type
    • 1.4.1. Global G-CSF Biosimilars Market Size Growth Rate by Product
    • 1.4.2. Human Growth Hormone
    • 1.4.3. Erythropoietin
    • 1.4.4. Monoclonal Antibodies
    • 1.4.5. Insulin
    • 1.4.6. Interferon
    • 1.4.7. Granulocyte-Colony Stimulating Factor
  • 1.5. Market by End User
    • 1.5.1. Global G-CSF Biosimilars Market Size Growth Rate by End User
    • 1.5.2. Blood Disorders
    • 1.5.3. Oncology Diseases
    • 1.5.4. Chronic And Autoimmune Diseases
    • 1.5.5. Growth Hormone Deficiencies
  • 1.6. Study Objectives
  • 1.7. Years Considered

2. Executive Summary

  • 2.1. Global G-CSF Biosimilars Market Size
    • 2.1.1. Global G-CSF Biosimilars Revenue 2014-2025
    • 2.1.2. Global G-CSF Biosimilars Sales 2014-2025
  • 2.2. G-CSF Biosimilars Growth Rate by Regions
    • 2.2.1. Global G-CSF Biosimilars Sales by Regions
    • 2.2.2. Global G-CSF Biosimilars Revenue by Regions

3. Breakdown Data by Manufacturers

  • 3.1. G-CSF Biosimilars Sales by Manufacturers
    • 3.1.1. G-CSF Biosimilars Sales by Manufacturers
    • 3.1.2. G-CSF Biosimilars Sales Market Share by Manufacturers
    • 3.1.3. Global G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI)
  • 3.2. G-CSF Biosimilars Revenue by Manufacturers
    • 3.2.1. G-CSF Biosimilars Revenue by Manufacturers (2014-2019)
    • 3.2.2. G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
  • 3.3. G-CSF Biosimilars Price by Manufacturers
  • 3.4. G-CSF Biosimilars Manufacturing Base Distribution, Product Types
    • 3.4.1. G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2. Manufacturers G-CSF Biosimilars Product Type
    • 3.4.3. Date of International Manufacturers Enter into G-CSF Biosimilars Market
  • 3.5. Manufacturers Mergers & Acquisitions, Expansion Plans

4. Breakdown Data by Product

  • 4.1. Global G-CSF Biosimilars Sales by Product
  • 4.2. Global G-CSF Biosimilars Revenue by Product
  • 4.3. G-CSF Biosimilars Price by Product

5. Breakdown Data by End User

  • 5.1. Overview
  • 5.2. Global G-CSF Biosimilars Breakdown Data by End User

6. North America

  • 6.1. North America G-CSF Biosimilars by Countries
    • 6.1.1. North America G-CSF Biosimilars Sales by Countries
    • 6.1.2. North America G-CSF Biosimilars Revenue by Countries
    • 6.1.3. United States
    • 6.1.4. Canada
    • 6.1.5. Mexico
  • 6.2. North America G-CSF Biosimilars by Product
  • 6.3. North America G-CSF Biosimilars by End User

7. Europe

  • 7.1. Europe G-CSF Biosimilars by Countries
    • 7.1.1. Europe G-CSF Biosimilars Sales by Countries
    • 7.1.2. Europe G-CSF Biosimilars Revenue by Countries
    • 7.1.3. Germany
    • 7.1.4. France
    • 7.1.5. UK
    • 7.1.6. Italy
    • 7.1.7. Russia
  • 7.2. Europe G-CSF Biosimilars by Product
  • 7.3. Europe G-CSF Biosimilars by End User

8. Asia Pacific

  • 8.1. Asia Pacific G-CSF Biosimilars by Countries
    • 8.1.1. Asia Pacific G-CSF Biosimilars Sales by Countries
    • 8.1.2. Asia Pacific G-CSF Biosimilars Revenue by Countries
    • 8.1.3. China
    • 8.1.4. Japan
    • 8.1.5. Korea
    • 8.1.6. India
    • 8.1.7. Australia
    • 8.1.8. Indonesia
    • 8.1.9. Malaysia
    • 8.1.10. Philippines
    • 8.1.11. Thailand
    • 8.1.12. Vietnam
    • 8.1.13. Singapore
  • 8.2. Asia Pacific G-CSF Biosimilars by Product
  • 8.3. Asia Pacific G-CSF Biosimilars by End User

9. Central & South America

  • 9.1. Central & South America G-CSF Biosimilars by Countries
    • 9.1.1. Central & South America G-CSF Biosimilars Sales by Countries
    • 9.1.2. Central & South America G-CSF Biosimilars Revenue by Countries
    • 9.1.3. Brazil
  • 9.2. Central & South America G-CSF Biosimilars by Product
  • 9.3. Central & South America G-CSF Biosimilars by End User

10. Middle East and Africa

  • 10.1. Middle East and Africa G-CSF Biosimilars by Countries
    • 10.1.1. Middle East and Africa G-CSF Biosimilars Sales by Countries
    • 10.1.2. Middle East and Africa G-CSF Biosimilars Revenue by Countries
    • 10.1.3. GCC Countries
    • 10.1.4. Turkey
    • 10.1.5. Egypt
    • 10.1.6. South Africa
  • 10.2. Middle East and Africa G-CSF Biosimilars by Product
  • 10.3. Middle East and Africa G-CSF Biosimilars by End User

11. Company Profiles

  • 11.1. Pfizer
    • 11.1.1. Pfizer Company Details
    • 11.1.2. Company Business Overview
    • 11.1.3. Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.1.4. Pfizer G-CSF Biosimilars Products Offered
    • 11.1.5. Pfizer Recent Development
  • 11.2. Novartis
    • 11.2.1. Novartis Company Details
    • 11.2.2. Company Business Overview
    • 11.2.3. Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.2.4. Novartis G-CSF Biosimilars Products Offered
    • 11.2.5. Novartis Recent Development
  • 11.3. Roche
    • 11.3.1. Roche Company Details
    • 11.3.2. Company Business Overview
    • 11.3.3. Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.3.4. Roche G-CSF Biosimilars Products Offered
    • 11.3.5. Roche Recent Development
  • 11.4. Merck & Co.
    • 11.4.1. Merck & Co. Company Details
    • 11.4.2. Company Business Overview
    • 11.4.3. Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.4.4. Merck & Co. G-CSF Biosimilars Products Offered
    • 11.4.5. Merck & Co. Recent Development
  • 11.5. Sanofi
    • 11.5.1. Sanofi Company Details
    • 11.5.2. Company Business Overview
    • 11.5.3. Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.5.4. Sanofi G-CSF Biosimilars Products Offered
    • 11.5.5. Sanofi Recent Development
  • 11.6. Johnson & Johnson
    • 11.6.1. Johnson & Johnson Company Details
    • 11.6.2. Company Business Overview
    • 11.6.3. Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.6.4. Johnson & Johnson G-CSF Biosimilars Products Offered
    • 11.6.5. Johnson & Johnson Recent Development
  • 11.7. Gilead Science
    • 11.7.1. Gilead Science Company Details
    • 11.7.2. Company Business Overview
    • 11.7.3. Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.7.4. Gilead Science G-CSF Biosimilars Products Offered
    • 11.7.5. Gilead Science Recent Development
  • 11.8. GlaxoSmithKline
    • 11.8.1. GlaxoSmithKline Company Details
    • 11.8.2. Company Business Overview
    • 11.8.3. GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.8.4. GlaxoSmithKline G-CSF Biosimilars Products Offered
    • 11.8.5. GlaxoSmithKline Recent Development
  • 11.9. AbbVie
    • 11.9.1. AbbVie Company Details
    • 11.9.2. Company Business Overview
    • 11.9.3. AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.9.4. AbbVie G-CSF Biosimilars Products Offered
    • 11.9.5. AbbVie Recent Development
  • 11.10. Amgen
    • 11.10.1. Amgen Company Details
    • 11.10.2. Company Business Overview
    • 11.10.3. Amgen G-CSF Biosimilars Sales, Revenue and Gross Margin (2014-2019)
    • 11.10.4. Amgen G-CSF Biosimilars Products Offered
    • 11.10.5. Amgen Recent Development
  • 11.11. AstraZeneca
  • 11.12. Bayer

12. Future Forecast

  • 12.1. G-CSF Biosimilars Market Forecast by Regions
    • 12.1.1. Global G-CSF Biosimilars Sales Forecast by Regions 2019-2025
    • 12.1.2. Global G-CSF Biosimilars Revenue Forecast by Regions 2019-2025
  • 12.2. G-CSF Biosimilars Market Forecast by Product
    • 12.2.1. Global G-CSF Biosimilars Sales Forecast by Product 2019-2025
    • 12.2.2. Global G-CSF Biosimilars Revenue Forecast by Product 2019-2025
  • 12.3. G-CSF Biosimilars Market Forecast by End User
  • 12.4. North America G-CSF Biosimilars Forecast
  • 12.5. Europe G-CSF Biosimilars Forecast
  • 12.6. Asia Pacific G-CSF Biosimilars Forecast
  • 12.7. Central & South America G-CSF Biosimilars Forecast
  • 12.8. Middle East and Africa G-CSF Biosimilars Forecast

13. Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1. Market Opportunities and Drivers
  • 13.2. Market Challenges
  • 13.3. Market Risks/Restraints
  • 13.4. Macroscopic Indicators

14. Value Chain and Sales Channels Analysis

  • 14.1. Value Chain Analysis
  • 14.2. G-CSF Biosimilars Customers
  • 14.3. Sales Channels Analysis
    • 14.3.1. Sales Channels
    • 14.3.2. Distributors

15. Research Findings and Conclusion

16. Appendix

  • 16.1. Research Methodology
    • 16.1.1. Methodology/Research Approach
    • 16.1.2. Data Source
  • 16.2. Author Details
  • 16.3. Disclaimer

List of Tables and Figures

  • Figure G-CSF Biosimilars Product Picture
  • Table G-CSF Biosimilars Market Segments
  • Table Key Manufacturers G-CSF Biosimilars Covered
  • Table Global G-CSF Biosimilars Market Size Growth Rate by Product 2019-2025 (Units) & (Million US$)
  • Figure Global G-CSF Biosimilars Sales Market Share by Product 2014-2025
  • Figure Human Growth Hormone Product Picture
  • Table Major Manufacturers of Human Growth Hormone
  • Figure Erythropoietin Product Picture
  • Table Major Manufacturers of Erythropoietin
  • Figure Monoclonal Antibodies Product Picture
  • Table Major Manufacturers of Monoclonal Antibodies
  • Figure Insulin Product Picture
  • Table Major Manufacturers of Insulin
  • Figure Interferon Product Picture
  • Table Major Manufacturers of Interferon
  • Figure Granulocyte-Colony Stimulating Factor Product Picture
  • Table Major Manufacturers of Granulocyte-Colony Stimulating Factor
  • Table Global G-CSF Biosimilars Market Size Growth Rate by End User 2019-2025 (Units)
  • Figure Blood Disorders
  • Figure Oncology Diseases
  • Figure Chronic And Autoimmune Diseases
  • Figure Growth Hormone Deficiencies
  • Figure G-CSF Biosimilars Report Years Considered
  • Figure Global G-CSF Biosimilars Market Size 2014-2025 (Million US$)
  • Figure Global G-CSF Biosimilars Sales 2014-2025 (Units)
  • Table Global G-CSF Biosimilars Market Size by Regions 2014-2019 (Units) & (Million US$)
  • Table Global G-CSF Biosimilars Sales by Regions 2014-2019 (Units)
  • Table Global G-CSF Biosimilars Sales Market Share by Regions 2014-2019
  • Figure Global G-CSF Biosimilars Sales Market Share by Regions 2014-2019
  • Figure 2018 Global G-CSF Biosimilars Sales Market Share by Regions
  • Table Global G-CSF Biosimilars Revenue by Regions 2014-2019 (Million US$)
  • Table Global G-CSF Biosimilars Revenue Market Share by Regions 2014-2019
  • Figure Global G-CSF Biosimilars Revenue Market Share by Regions 2014-2019
  • Figure 2018 Global G-CSF Biosimilars Revenue Market Share by Regions
  • Table Global G-CSF Biosimilars Sales by Manufacturers (2014-2019) (Units)
  • Table Global G-CSF Biosimilars Sales Share by Manufacturers (2014-2019)
  • Figure Global G-CSF Biosimilars Sales Share by Manufacturers in 2018
  • Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table G-CSF Biosimilars Revenue by Manufacturers (2014-2019) (Million USD)
  • Table G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
  • Figure G-CSF Biosimilars Value Share by Manufacturers in 2018
  • Table Key Manufacturers G-CSF Biosimilars Price (2014-2019) (USD/Unit)
  • Table G-CSF Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
  • Table Manufacturers G-CSF Biosimilars Product Type
  • Table Date of International Manufacturers Enter into G-CSF Biosimilars Market
  • Table Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table Global G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table Global G-CSF Biosimilars Sales Share by Product (2014-2019)
  • Figure Global G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure Global G-CSF Biosimilars Sales Market Share by Product in 2018
  • Table Global G-CSF Biosimilars Revenue by Product (2014-2019) (Million US$)
  • Table Global G-CSF Biosimilars Revenue Share by Product (2014-2019)
  • Figure Global G-CSF Biosimilars Revenue Market Share by Product (2014-2019)
  • Figure Global G-CSF Biosimilars Revenue Market Share by Product in 2018
  • Table G-CSF Biosimilars Price by Product 2014-2019 (USD/Unit)
  • Table Global G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table Global G-CSF Biosimilars Sales Share by End User (2014-2019)
  • Figure Global Sales G-CSF Biosimilars Market Share by End User (2014-2019)
  • Figure Global Sales G-CSF Biosimilars Market Share by End User in 2018
  • Figure North America G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
  • Figure North America G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
  • Table North America G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
  • Table North America G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
  • Figure 2018 North America G-CSF Biosimilars Sales Market Share by Countries
  • Table North America G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
  • Table North America G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
  • Figure 2018 North America G-CSF Biosimilars Revenue Market Share by Countries
  • Figure United States G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure United States G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Units)
  • Figure Canada G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Canada G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Mexico G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Mexico G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Table North America G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table North America G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure 2018 North America G-CSF Biosimilars Market Share by Product
  • Table North America G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table North America G-CSF Biosimilars Sales Market Share by End User (2014-2019)
  • Figure 2018 North America G-CSF Biosimilars Market Share by End User
  • Figure Europe G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
  • Figure Europe G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
  • Table Europe G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
  • Table Europe G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
  • Figure 2018 Europe G-CSF Biosimilars Sales Market Share by Countries
  • Table Europe G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
  • Table Europe G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
  • Figure 2018 Europe G-CSF Biosimilars Revenue Market Share by Countries
  • Figure Germany G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Germany G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure France G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure France G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure UK G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure UK G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Italy G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Italy G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Russia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Russia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Table Europe G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table Europe G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure 2018 Europe G-CSF Biosimilars Market Share by Product
  • Table Europe G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table Europe G-CSF Biosimilars Sales Market Share by End User (2014-2019)
  • Figure 2018 Europe G-CSF Biosimilars Market Share by End User
  • Figure Asia Pacific G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
  • Figure Asia Pacific G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
  • Table Asia Pacific G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
  • Table Asia Pacific G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
  • Figure 2018 Asia Pacific G-CSF Biosimilars Sales Market Share by Countries
  • Table Asia Pacific G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
  • Table Asia Pacific G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
  • Figure 2018 Asia Pacific G-CSF Biosimilars Revenue Market Share by Countries
  • Figure China G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure China G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Japan G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Japan G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Korea G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Korea G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure India G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure India G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Australia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Australia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Indonesia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Indonesia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Malaysia G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Malaysia G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Philippines G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Philippines G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Thailand G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Thailand G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Vietnam G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Vietnam G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Singapore G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Singapore G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Table Asia Pacific G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table Asia Pacific G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure 2018 Asia Pacific G-CSF Biosimilars Market Share by Product
  • Table Asia Pacific G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table Asia Pacific G-CSF Biosimilars Sales Market Share by End User (2014-2019)
  • Figure 2018 Asia Pacific G-CSF Biosimilars Market Share by End User
  • Figure Central & South America G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
  • Figure Central & South America G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
  • Table Central & South America G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
  • Table Central & South America G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
  • Figure 2018 Central & South America G-CSF Biosimilars Sales Market Share by Countries
  • Table Central & South America G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
  • Table Central & South America G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
  • Figure 2018 Central & South America G-CSF Biosimilars Revenue Market Share by Countries
  • Figure Brazil G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Brazil G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Argentina G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Argentina G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Table Central & South America G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table Central & South America G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure 2018 Central & South America G-CSF Biosimilars Market Share by Product
  • Table Central & South America G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table Central & South America G-CSF Biosimilars Sales Market Share by End User (2014-2019)
  • Figure 2018 Central & South America G-CSF Biosimilars Market Share by End User
  • Figure Middle East and Africa G-CSF Biosimilars Sales Growth Rate 2014-2019 (Units)
  • Figure Middle East and Africa G-CSF Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
  • Table Middle East and Africa G-CSF Biosimilars Sales by Countries (2014-2019) (Units)
  • Table Middle East and Africa G-CSF Biosimilars Sales Market Share by Countries (2014-2019)
  • Figure 2018 Middle East and Africa G-CSF Biosimilars Sales Market Share by Countries
  • Table Middle East and Africa G-CSF Biosimilars Revenue by Countries (2014-2019) (Million US$)
  • Table Middle East and Africa G-CSF Biosimilars Revenue Market Share by Countries (2014-2019)
  • Figure 2018 Middle East and Africa G-CSF Biosimilars Revenue Market Share by Countries
  • Figure GCC Countries G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure GCC Countries G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Turkey G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Turkey G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Egypt G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure Egypt G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Figure South Africa G-CSF Biosimilars Sales Growth Rate (2014-2019) (Units)
  • Figure South Africa G-CSF Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
  • Table Middle East and Africa G-CSF Biosimilars Sales by Product (2014-2019) (Units)
  • Table Middle East and Africa G-CSF Biosimilars Sales Market Share by Product (2014-2019)
  • Figure 2018 Middle East and Africa G-CSF Biosimilars Market Share by Product
  • Table Middle East and Africa G-CSF Biosimilars Sales by End User (2014-2019) (Units)
  • Table Middle East and Africa G-CSF Biosimilars Sales Market Share by End User (2014-2019)
  • Figure 2018 Middle East and Africa G-CSF Biosimilars Market Share by End User
  • Table Pfizer Company Details
  • Table Pfizer G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Pfizer Recent Development
  • Table Novartis Company Details
  • Table Novartis G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Novartis Recent Development
  • Table Roche Company Details
  • Table Roche G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Roche Recent Development
  • Table Merck & Co. Company Details
  • Table Merck & Co. G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Merck & Co. Recent Development
  • Table Sanofi Company Details
  • Table Sanofi G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Sanofi Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Gilead Science Company Details
  • Table Gilead Science G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Gilead Science Recent Development
  • Table GlaxoSmithKline Company Details
  • Table GlaxoSmithKline G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table GlaxoSmithKline Recent Development
  • Table AbbVie Company Details
  • Table AbbVie G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table AbbVie Recent Development
  • Table Amgen Company Details
  • Table Amgen G-CSF Biosimilars Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Amgen Recent Development
  • Table AstraZeneca Company Details
  • Table Bayer Company Details
  • Table Global G-CSF Biosimilars Sales Forecast by Regions 2019-2025 (Units)
  • Table Global G-CSF Biosimilars Sales Market Share Forecast by Regions 2019-2025
  • Table Global G-CSF Biosimilars Revenue Forecast by Regions 2019-2025 (Million US$)
  • Table Global G-CSF Biosimilars Revenue Market Share Forecast by Regions 2019-2025
  • Table Global G-CSF Biosimilars Sales Forecast by Product 2019-2025 (Units)
  • Table Global G-CSF Biosimilars Sales Market Share Forecast by Product 2019-2025
  • Table Global G-CSF Biosimilars Revenue Forecast by Product 2019-2025 (Million US$)
  • Table Global G-CSF Biosimilars Revenue Market Share Forecast by Product 2019-2025
  • Table Global G-CSF Biosimilars Sales Forecast by End User 2019-2025 (Units)
  • Table Global G-CSF Biosimilars Sales Market Share Forecast by End User 2019-2025
  • Figure North America G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
  • Figure North America G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
  • Figure Europe G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
  • Figure Europe G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
  • Figure Asia Pacific G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
  • Figure Asia Pacific G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
  • Figure Central & South America G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
  • Figure Central & South America G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
  • Figure Middle East and Africa G-CSF Biosimilars Sales Growth Rate Forecast (2019-2025) (Units)
  • Figure Middle East and Africa G-CSF Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
  • Table G-CSF Biosimilars Value Chain
  • Table G-CSF Biosimilars Customers List
  • Table G-CSF Biosimilars Distributors List
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top